Novolin 70/30 Vial Carton (Image 01)
Novolin Injection, Suspension
Product Images NDC 0169-1837
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 34 technical images submitted to the FDA as part of the official labeling for Novolin (NDC 0169-1837). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Novolin 70/30 Relion Vial Carton (Image 02)
Novolin is a brand of insulin injections that contains a combination of human insulin isophane suspension and human insulin injection. The provided packaging comes in U-100, with an NDC code of 0160-1837-11. It is advised to be used with U-100 insulin and to keep under medical supervision, stored in a refrigerator. It is manufactured by Novo Nordisk and comes in the Novolin B 70/30 formulation. Contact information for the manufacturer is also included.*
Image 03
Novolin® W70/30 is a type of human insulin medication that comes in an isophane suspension form. The medication is designed to be used with U-100 insulin and should be injected carefully. It is recommended to store the medication in a refrigerator below 77°F. For more information, contact the medical supplier mentioned on the packaging.*
Image 04
This is a product description for a medication called GRS. The text includes dosage information and a warning to administer cautiously, as well as a list of other medications. It also includes a patent information and contact details for the drug manufacturer, Novo Nordisk. However, there is some garbled text which is unreadable and makes it difficult to understand the full context.*
Image 05
This is a description of the Novolin 70/30 FlexPen, a medication injection used in treating diabetes. The text gives information about its chemical properties, dosage amounts, and instructions on proper usage. It also includes a warning to be cautious when administering the medicine and to follow proper technique. The medication contains phenol and metscsol 35 Shrenaine, and is not recommended for individuals with specific allergies or medical conditions. The text also mentions patent information and the manufacturer, Novo Nordik.*
Image 12
Image 13
Image 14
NovoFine, NovoFine Plus, and NovoTwist are names of medical products, possibly needles or syringe attachments. "Bigouer" and "Bigower" are unclear and could be misspellings. The text also includes references to "4p stk Pty," "4p ootk Pt," and "@333" which are not readily discernible. The phrase "0% o Y S A" is also unclear and appears to be incomplete. The final line mentions a "needlecap" and a company or brand called "Nasdh Brotetis s". Overall, the text is difficult to interpret and provide a useful description.*
Image 15
Image 16
Image 17
Image 18
Image 19
Image 20
Image 21
Image 22
Image 23
Image 24
Image 25
Image 26
Image 27
Image 28
Image 29
Image 30
Image 31
Image 32
Image 33
Image 34
Image 35
Image 36
Image 37
Image 38
Image 39
Image 40
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
